AnPac Bio-Medical Science Co., Ltd.
ANPC · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $62 | $105 | $387 | $773 |
| - Cash | $2 | $9 | $3 | $6 |
| + Debt | $12 | $34 | $8 | $39 |
| Enterprise Value | $72 | $130 | $392 | $805 |
| Revenue | $12 | $18 | $21 | $11 |
| % Growth | -33% | -12.3% | 89.1% | – |
| Gross Profit | $8 | $12 | $13 | $5 |
| % Margin | 69.2% | 68.1% | 62.8% | 44.2% |
| EBITDA | -$100 | -$112 | -$77 | -$93 |
| % Margin | -827.1% | -623.2% | -377.5% | -860.7% |
| Net Income | -$104 | -$120 | -$81 | -$102 |
| % Margin | -860.2% | -667.7% | -392.8% | -937% |
| EPS Diluted | -54.18 | -176.53 | -143.99 | -205.96 |
| % Growth | 69.3% | -22.6% | 30.1% | – |
| Operating Cash Flow | -$55 | -$72 | -$59 | -$49 |
| Capital Expenditures | -$2 | -$4 | -$2 | -$3 |
| Free Cash Flow | -$57 | -$76 | -$61 | -$52 |